COVID-19 UPDATES: Click here to read more!
Click here to get on our COVID-19 Waiting List

Get Healthy!

  • Posted June 23, 2025

GLP-1 Therapy Helps Cut Migraine Frequency, Study Finds

In a new observational study, patients with migraine given a daily dose of liraglutide, a popular GLP-1 receptor agonist, reported significantly fewer headache days and an improved quality of life.

Health News is provided as a service to Seip Drug site users by HealthDay. Seip Drug nor its employees, agents, or contractors, review, control, or take responsibility for the content of these articles. Please seek medical advice directly from your pharmacist or physician.
Copyright © 2025 HealthDay All Rights Reserved.

Share

Tags